Co-administered Therapeutics

CAR peptide can be co-administered with other medications to increase localized therapeutic bioavailability, boost therapeutic efficacy in a targeted manner, and minimize systemic side effects.

As CAR peptide homes to, and penetrates  areas of disease activity, co-administered medicines will preferentially accumulate in these diseased areas resulting in higher localized therapeutic concentrations. By causing co-administered therapeutics to achieve higher concentrations in diseased tissue, CAR peptide enables targeted therapies that are localized to the areas of disease. By concentrating co-administered therapeutics in the areas of disease, CAR peptide can also reduce off-target systemic side effects.

Next Steps:

DISCLAIMER: The material provided on this site is strictly for informational purposes. Do not use this site as a substitute for medical care or medical advice. Please consult with your physician or other medical care provider regarding any medical questions you may have.

Products & Services